Pharmacoepidemiology and Drug Safety Journal Citation Rate 2026

ISSN 1053-8569 eISSN 1099-1557 Wiley GB

Q2 Quartile Verified Publisher

About Pharmacoepidemiology and Drug Safety
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Pharmacoepidemiology and Drug Safety (PDS) is a peer-reviewed academic journal covering Advanced Causal Inference Techniques and Medication Adherence and Compliance, published by Wiley in GB, catalogued under ISSN 1053-8569 (e-ISSN 1099-1557). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.65 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4740 USD).

Pharmacoepidemiology and Drug Safety Citation Rate 2026 — In Context

Pharmacoepidemiology and Drug Safety has a 2025 2-Year Citation Rate (OpenAlex) of 1.65, placing it in the Q2 quartile within the Advanced Causal Inference Techniques research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Pharmacoepidemiology and Drug Safety operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Pharmacoepidemiology and Drug Safety should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Pharmacoepidemiology and Drug Safety against similar journals in the field, use our journal comparison tool.

Submission Tips for Pharmacoepidemiology and Drug Safety
  • Budget $4740 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Advanced Causal Inference Techniques, Medication Adherence and Compliance, Pharmaceutical Practices and Patient Outcomes. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Pharmacoepidemiology and Drug … Compares
Citation Rate vs Field Avg
+55%
Field avg: 1.07
APC vs Field Avg
+55%
Field avg: $3068

Compared against 5 journals in the same research areas.

ISSN (Print) 1053-8569
ISSN (Online) 1099-1557
Publisher Wiley
Country United Kingdom
APC / Cost $4740 USD
In-depth profile & metrics

Pharmacoepidemiology and Drug Safety is published by Wiley and based in United Kingdom. It runs on a subscription or hybrid model with an article-processing charge of USD 4740.

In our subject taxonomy, Pharmacoepidemiology and Drug Safety is classified under Advanced Causal Inference Techniques, Medication Adherence and Compliance, Pharmaceutical Practices and Patient Outcomes and Pharmaceutical studies and practices.

Pharmacoepidemiology and Drug Safety is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 1.647.

Research Areas
Links
Frequently Asked Questions about Pharmacoepidemiology and Drug Safety

Pharmacoepidemiology and Drug Safety does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 1.647 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Pharmacoepidemiology and Drug Safety is not an open access journal.

The Article Processing Charge (APC) for Pharmacoepidemiology and Drug Safety is $4740 USD.

Pharmacoepidemiology and Drug Safety is published by Wiley.

Pharmacoepidemiology and Drug Safety shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Pharmacoepidemiology and Drug Safety is 1053-8569. Its electronic ISSN (eISSN) is 1099-1557.

Pharmacoepidemiology and Drug Safety sits in the Q2 quartile based on its latest impact factor of 1.65, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
1.647
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 1.647 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S140231191

Get weekly updates for Advanced Causal Inference Techniques journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google